| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |